The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growthJanet K. Parrish, Paul Jedlicka|Oncotarget|2018Cited by 53